GBP1(+) cases |
1 |
Tongue |
53 |
Male |
Well |
T4N2bM0 |
IV |
Chemoradiation→operation |
40 |
Recurrent |
2 |
Tongue |
54 |
Female |
Well |
T2N0M0 |
II |
Chemoradiation→operation |
40 |
Recurrent and lymph node metastasis |
3 |
Larynx |
57 |
Male |
Moderate |
T2N0M0 |
II |
Radiation |
70 |
Lymph node metastasis |
4 |
Larynx |
59 |
Male |
Moderate |
T2N0M0 |
II |
Chemoradiation |
70 |
Recurrent |
5 |
Buccal cavity |
59 |
Male |
Moderate |
T1N2 cM0 |
IV |
Chemoradiation→operation |
70 |
Lymph node metastasis |
6 |
Buccal cavity |
60 |
Male |
Well |
T4N2bM1 |
IV |
Chemoradiation→operation |
40 |
Recurrent |
7 |
Paranasal sinus |
60 |
Male |
Well > poor |
T3N0M0 |
III |
Chemoradiation→operation |
70 |
Recurrent and lymph node metastasis |
8 |
Paranasal sinus |
60 |
Male |
Moderate |
T3N0M0 |
III |
Chemoradiation→operation |
50 |
Recurrent |
9 |
Paranasal sinus |
60 |
Female |
Moderate |
T3N0M0 |
III |
Chemoradiation→operation |
50 |
Recurrent |
10 |
Paranasal sinus |
61 |
Male |
Moderate |
T3N0M0 |
III |
Chemoradiation→operation |
50 |
Lymph node metastasis |
11 |
Larynx |
67 |
Male |
Moderate |
T2N0M0 |
II |
Radiation |
72 |
Recurrent |
12 |
Paranasal sinus |
69 |
Male |
Poor |
T3N0M0 |
III |
Chemoradiation→operation |
50 |
Pathologically no recurrent/ CR over 5 years |
13 |
Hypopharynx |
69 |
Male |
Well > moderate |
T4N2 cM0 |
IV |
Chemotherapy→operation→radiation |
63 |
Recurrent and lung metastatis |
14 |
Hypopharynx |
71 |
Male |
Moderate |
T2N0M0 |
II |
Chemoradiation→operation |
70 |
Recurrent |
15 |
Paranasal sinus |
74 |
Male |
Moderate |
T4N1M0 |
IV |
Radiation→operation |
50 |
Recurrent |
16 |
Paranasal sinus |
75 |
Female |
Well |
T4N2bM0 |
IV |
Chemoradiation |
60 |
Recurrent |
17 |
Buccal cavity |
76 |
Male |
Well |
T2N0M0 |
II |
Chemoradiation→operation |
50 |
Lymph node and lung metastasis |
18 |
Buccal cavity |
79 |
Female |
Well |
T4N2 cM0 |
IV |
Chemoradiation→operation |
40 |
Recurrent and lymph node metastasis |
19 |
Larynx |
79 |
Male |
Moderate > well |
T1bN0M0 |
I |
Radiation |
66 |
Recurrent |
20 |
Buccal cavity |
80 |
Female |
Well |
T4N2bM0 |
IV |
Chemoradiation→operation |
60 |
Recurrent and lymph node metastasis |
21 |
Larynx |
81 |
Male |
Well > moderate |
T1aN0M0 |
I |
Radiation |
66 |
Recurrent |
GBP1(−) |
22 |
Paranasal sinus |
46 |
Male |
Well |
T3N0M0 |
III |
Chemoradiationmoradiatin |
50 |
Recurrent and lymph node metastasis |
23 |
Larynx |
51 |
Male |
Well |
T2N0M0 |
I |
Radiation→operation |
66 |
Recurrent |
24 |
Oropharynx |
54 |
Male |
Poor |
T4N2 cM0 |
IV |
Chemoradiation→operation |
77 |
Recurrent |
25 |
Paranasal sinus |
56 |
Male |
Moderate > well |
T3N0M0 |
III |
Chemoradiationoradia wel |
70 |
Recurrent |
26 |
Paranasal sinus |
57 |
Male |
Moderate |
T3N0M0 |
III |
Chemoradiation→operation |
50 |
Recurrent |
27 |
Oropharynx |
57 |
Male |
Moderate |
T2N3M0 |
IV |
Chemoradiation→operation |
60 |
Recurrent |
28 |
Paranasal sinus |
57 |
Male |
Moderate > poor |
T3N2bM0 |
IV |
Chemoradiationmoradiatpo |
50 |
Recurrent and lymph node metastasis |
29 |
Paranasal sinus |
60 |
Male |
Poor |
T3N0M0 |
III |
Chemoradiation→operation |
50 |
Pathologically no recurrent/ CR over 5 years |
30 |
Larynx |
61 |
Male |
Moderate > well |
T2N0M0 |
II |
Chemoradiation |
70 |
Pathologically no recurrent/ CR over 5 years |
31 |
Rhinopharynx |
61 |
Male |
Moderate |
T1N2bM0 |
IIB |
Chemoradiation→operation |
70 |
Pathologically no recurrent/ CR over 5 years |
32 |
Oropharynx |
66 |
Male |
Poor |
T3N3M0 |
IV |
Chemoradiation→operation |
70 |
Pathologically no recurrent/ CR over 5 years |
33 |
Buccal cavity |
67 |
Male |
Well |
T4N2 cM1 |
IV |
Chemoradiation→operation |
40 |
Recurrent and lymph node metastasis |
34 |
Tongue |
68 |
Male |
Moderate |
T1N0M0 |
I |
Radiation |
70 |
Pathologically no recurrent/ CR over 5 years |
35 |
Paranasal sinus |
69 |
Male |
Moderate ˜ well |
T4N2bM0 |
IV |
Chemoradiation→operation |
50 |
Recurrent |
36 |
Paranasal sinus |
71 |
Male |
Moderate > well |
T3N0M0 |
III |
Chemoradiation→operation |
50 |
Pathologically no recurrent/ CR over 5 years |
37 |
Larynx |
71 |
Male |
Well |
T1N0M0 |
I |
Radiation→operation |
66 |
Recurrent |
38 |
Paranasal sinus |
71 |
Female |
Well |
T4N0M0 |
IV |
Chemoradiationinustionec |
50 |
Recurrent |
39 |
Paranasal sinus |
72 |
Male |
Moderate |
T4N0M0 |
IV |
Chemoradiation→operation |
50 |
Recurrent |
40 |
Buccal cavity |
74 |
Male |
Well |
T4N2bM0 |
IV |
Chemoradiation→operation |
40 |
Recurrent |
41 |
Buccal cavity |
75 |
Female |
Well |
T4N1M0 |
IV |
Chemoradiation→operation |
48 |
Recurrent |
42 |
Paranasal sinus |
76 |
Female |
Moderate |
T3N0M0 |
III |
Chemoradiation→operation |
60 |
Recurrent |
43 |
Paranasal sinus |
77 |
Male |
Moderate |
T4N0M0 |
IV |
Chemoradiation→operation |
50 |
Recurrent |
44 |
Tongue |
80 |
Male |
Well |
T2N0M0 |
II |
Radiation |
70 |
Recurrent |
45 |
Larynx |
82 |
Male |
Well |
T1N0M0 |
I |
Radiation |
66 |
Pathologically no recurrent/ CR over 5 years |